Medpace

Overview

Medpace is a full-service contract research organization (CRO) structured around a "one team" approach to clinical development. The organization emphasizes quality, team continuity, and integrated service delivery across the complete clinical trial lifecycle.

Service Model

Medpace operates as a full-service outsourcing (FSO) partner, coordinating and integrating all services for clients through a single cross-functional team. This model is designed to reduce duplicate management oversight and embed medical, regulatory, and operational expertise directly into client trials. The organization maintains continuity by assigning one team throughout the project lifecycle, from early planning through close-out.

Integrated Infrastructure

The company operates wholly-owned central laboratories, bioanalytical laboratory, imaging core lab, ECG core lab, and Phase I unit. These in-house capabilities are supported by a proprietary Clinical Trial Management System that consolidates study data across all services.

Therapeutic Expertise

Medpace employs a high-science and disciplined operating approach with regulatory and therapeutic expertise across major therapeutic areas. The organization leverages relationships with Key Opinion Leaders, Principal Investigators, and high-performing sites to accelerate clinical development.

Global Reach

The company operates across North America, Europe, Latin America, and Asia Pacific, with country-specific experience and in-house expertise to navigate languages, cultures, and clinical and regulatory environments globally.

Organizational Stability

The organization has grown organically for over 30 years, preserving its unique approach and avoiding disruptions associated with mergers and acquisitions.